Atypical presentation of parvovirus infection [1]

Pediatric Infectious Disease Journal

Volumn 24, Issue 3, 2005, Pages 283-284

  Weinstein, Michael ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; VIRUS DNA;

ADOLESCENT; ANAMNESIS; BACTERIUM DETECTION; BLOOD CULTURE; BLOOD EXAMINATION; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; CONVALESCENCE; HUMAN; INTUBATION; LABORATORY TEST; LETTER; MALE; PARVOVIRUS; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESUSCITATION; SEROLOGY; THROMBOCYTE TRANSFUSION; URINE CULTURE; VIRUS INFECTION;

ADOLESCENT; COMBINED MODALITY THERAPY; CRITICAL CARE; CRITICAL ILLNESS; EMERGENCY SERVICE, HOSPITAL; FOLLOW-UP STUDIES; HUMANS; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RISK ASSESSMENT; TREATMENT OUTCOME; VIREMIA;

EID: 14944374060     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000154592.43324.81     Document Type: Letter

References (4)

1. Takahashi T, Ozawa K, Takahashi K, Asano S, Takaku F. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood. 1990;75:603-610.
2. Kellermayer R, Faden H, Grossi M. Clinical presentation of parvovirus B19 infection in children with aplastic crisis. Pediatr Infect Dis J. 2003;22:1100-1101.
3. Pont J, Puchhammer-Stockl E, Chott A, et al. Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Haematol. 1992;80:160-165.
4. Kurtzman GJ, Cohen BJ, Field AM, et al. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest. 1989;84:1114-1123.